These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2039196)
1. Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii. Matsuda K; Sanada M; Nakagawa S; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1991 Mar; 35(3):458-61. PubMed ID: 2039196 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relations of 4-fluoromethyl monobactams. Matsuda K; Nakagawa S; Nakano F; Inoue M; Mitsuhashi S J Antimicrob Chemother; 1987 Jun; 19(6):753-60. PubMed ID: 3497148 [TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria. Raimondi A; Cocuzza CE J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698 [TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. Cantu C; Huang W; Palzkill T J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421 [TBL] [Abstract][Full Text] [Related]
5. New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis. Lohans CT; Brem J; Schofield CJ Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971873 [No Abstract] [Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165. Neu HC; Chin NX Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528 [TBL] [Abstract][Full Text] [Related]
7. Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria. Bush K; Freudenberger JS; Sykes RB Antimicrob Agents Chemother; 1982 Sep; 22(3):414-20. PubMed ID: 6982680 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1983 Aug; 24(2):227-32. PubMed ID: 6605715 [TBL] [Abstract][Full Text] [Related]
9. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228. Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873 [TBL] [Abstract][Full Text] [Related]
10. Active-Site Protonation States in an Acyl-Enzyme Intermediate of a Class A β-Lactamase with a Monobactam Substrate. Vandavasi VG; Langan PS; Weiss KL; Parks JM; Cooper JB; Ginell SL; Coates L Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795378 [TBL] [Abstract][Full Text] [Related]
11. Discovery and development of the monobactams. Sykes RB; Bonner DP Rev Infect Dis; 1985; 7 Suppl 4():S579-93. PubMed ID: 3909315 [TBL] [Abstract][Full Text] [Related]
12. Further occurrence of extended-spectrum beta-lactamase-producing Salmonella enteritidis. Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Krcméryová T; Kubonová K J Chemother; 1998 Aug; 10(4):291-4. PubMed ID: 9720467 [TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production. Brown J; Yang YJ; Livermore DM J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102 [TBL] [Abstract][Full Text] [Related]
14. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [TBL] [Abstract][Full Text] [Related]
18. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A; Mattina R; Cocuzza CE Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [TBL] [Abstract][Full Text] [Related]
19. A review of the pharmacokinetics and pharmacodynamics of aztreonam. Ramsey C; MacGowan AP J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial evaluation of new monobactams. Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]